Health Care · owned by 1 fund manager
Who owns Lakefront Biotherapeutics (LKFT)?
1 of the 22 fund managers we track hold Lakefront Biotherapeutics, worth $14M combined as of Q2 2026. David Einhorn has the biggest bet at 0.4% of the portfolio.
Ownership summary
Fund manager owners
1 / 22
0 opened new positions
Combined value
$14M
At quarter-end prices
Biggest weight
0.4%
David Einhorn
Buyers / sellers
0 / 0
Changes in Q2 2026
Smart money take
Why it matters
When several investors with very different styles own the same company, it’s often worth a closer look. Lakefront Biotherapeutics appears in 1 of our 22 portfolios.
- Largest holder: David Einhorn (0.4% of portfolio)
- 0 managers bought or added this quarter
- 0 managers trimmed or sold out
This is not a recommendation. Do your own research.
Fund managers who own LKFT
SEC 13F · Q2 2026| Investor | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| David Einhorn Greenlight Capital | 0.37% | Hold | 482,746 | $14M |
Coming soon · QWERTx Pro
Professionally managed portfolios, built around your life.
We are building QWERTx Pro: portfolios matched to your risk profile and time horizon, managed by experienced financial advisors. Join the waitlist to hear first when it launches.
